Knightscope Falls 30% Following $1.7M Direct Offering
Knightscope, Inc. (KSCP), part of the PRISM NextGen Tech & AI Index, fell sharply midday, losing nearly a third of its value, after announcing a $1.7 million registered direct offering of common stock. The security robotics company entered into agreements to sell 625,000 shares at $2.75 apiece, pricing the deal below its recent trading levels. The offering, facilitated exclusively by H.C. Wainwright & Co., is expected to close around March 31, pending standard closing conditions. Proceeds are slated for general corporate purposes and working capital as Knightscope continues expanding its AI-powered security solutions. Investors reacted negatively to the dilution, even as the firm maintains a long-term vision to revolutionize public safety through robotics and smart technologies.
Plus Therapeutics Slides 22% on Earnings and 2025 Guidance
Shares of Plus Therapeutics, Inc. (PSTV), a PRISM Emerging Biotech Index name also sank midday, retreating 22% despite notable progress across its radiotherapeutic programs. The company recently completed a $15 million private placement, which extended its financial runway into 2026 and enabled compliance with Nasdaq equity requirements. Full-year 2024 results showed a net loss of $13.0 million, slightly improved from the prior year. However, mounting R&D and administrative expenses, along with a sharp year-end cash decline to just $76,000, weighed on sentiment.
Operationally, Plus is positioning for a potential breakout year. The firm is advancing its lead asset, REYOBIQ™, for CNS cancers including glioblastoma and leptomeningeal metastases (LM), backed by strong early survival data and FDA orphan drug designation. In parallel, the company is preparing for the commercial debut of its CNSide™ diagnostic platform, designed to identify and monitor tumor cells in cerebrospinal fluid. Investors will be watching closely for key 2025 milestones, including regulatory updates, clinical trial progression, and revenue generation from CNSide.
Other PRISM Mid-Day Movers:
- IO Biotech, Inc. (IOBT) up 23%
- Tonix Pharmaceuticals Holding Corp. (TNXP) down 22%
- Greenland Technologies Holding Corp. (GTEC) down 16.6%
- Spectral AI Inc. (MDAI) down 16.4%
- Equillium Inc. (EQ) down 16.2%
The post PRISM Mid-Day Movers: Market Slump Hits Emerging Biotech and NextGen Tech & AI Stocks appeared first on PRISM MarketView.
